NVS logo

Novartis AG (NVS) Return On Equity

Annual ROE

27.97%
+17.04%+155.90%

31 December 2023

1-Year Change

+155.9%
NVS annual return on equity is up +155.9% year-on-year

3-Year Change

+94.37%
NVS annual return on equity is up +94.37% over the past 3 years

All-time High

38.59%
NVS annual return on equity is currently -27.52% below its historical high of 38.59%

Sector Rank

85.09%
NVS annual return on equity is higher than 85.09% of companies in Healthcare sector

Annual ROE Formula

Net Income
Shareholders Equity
✕ 100%
Annual Net Income$14.85 B
NVS annual net profit is $14.85 billion
Annual Shareholders Equity$46.67 B
NVS annual stockholders equity is $46.67 billion
Price$105.25
NVS price is $105.25

NVS ROE Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly ROE

41.89%
+4.89%+13.22%

30 September 2024

1-Year Change

+180.76%
NVS quarterly return on equity is up +180.76% year-on-year

3-Year Change

+133.11%
NVS quarterly return on equity is up +133.11% over the past 3 years

All-time High

41.97%
NVS quarterly return on equity is currently -0.19% below its historical high of 41.97%

Sector Rank

87.18%
NVS quarterly return on equity is higher than 87.18% of companies in Healthcare sector
Quarterly Net Income$3.19 B
NVS quarterly net profit is $3.19 billion
Quarterly Shareholders Equity$43.32 B
NVS quarterly stockholders equity is $43.32 billion
Annual ROE27.97%
NVS annual return on equity is 27.97%
Price$105.25
NVS price is $105.25

NVS Quarterly ROE Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NVS ROE Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+155.9%+180.8%
3 y3 years+94.4%+133.1%
5 y5 years+69.6%+118.8%

NVS ROE High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-27.5%+155.9%-0.2%+276.7%
5 y5 years-27.5%+155.9%-0.2%+276.7%
alltimeall time-27.5%+216.8%-0.2%+376.6%

Novartis AG ROE History

DateAnnualQuarterly
Sept 2024
-
41.89%(+13.2%)
June 2024
-
37.00%(+11.1%)
Mar 2024
-
33.31%(+11.5%)
Dec 2023
27.97%(+155.9%)
29.88%(+100.3%)
Sept 2023
-
14.92%(+12.1%)
June 2023
-
13.31%(+12.6%)
Mar 2023
-
11.82%(+6.3%)
Dec 2022
10.93%(-71.7%)
11.12%(-68.3%)
Sept 2022
-
35.11%(-7.2%)
June 2022
-
37.85%(-8.9%)
Mar 2022
-
41.53%(-1.0%)
Dec 2021
38.59%(+168.2%)
41.97%(+133.6%)
Sept 2021
-
17.97%(+7.9%)
June 2021
-
16.65%(+11.6%)
Mar 2021
-
14.92%(+0.4%)
Dec 2020
14.39%(-17.7%)
14.86%(+12.0%)
Sept 2020
-
13.27%(-2.6%)
June 2020
-
13.63%(-42.1%)
Mar 2020
-
23.54%(+14.6%)
Dec 2019
17.48%(+6.0%)
20.54%(+7.3%)
Sept 2019
-
19.15%(+11.9%)
June 2019
-
17.12%(-2.4%)
Mar 2019
-
17.54%(+5.4%)
Dec 2018
16.49%(+59.6%)
16.64%(-7.3%)
Sept 2018
-
17.96%(-5.4%)
June 2018
-
18.99%(+67.5%)
Mar 2018
-
11.34%(+5.7%)
Dec 2017
10.33%(+17.0%)
10.73%(+15.6%)
Sept 2017
-
9.28%(+2.2%)
June 2017
-
9.08%(+3.3%)
Mar 2017
-
8.79%(-2.7%)
Dec 2016
8.83%(-63.3%)
9.03%(-1.0%)
Sept 2016
-
9.12%(+1.8%)
June 2016
-
8.96%(+0.6%)
Mar 2016
-
8.91%(-61.9%)
Dec 2015
24.04%(+71.1%)
23.40%(-3.9%)
Sept 2015
-
24.34%(-8.4%)
June 2015
-
26.56%(-5.8%)
Mar 2015
-
28.19%(+97.4%)
Dec 2014
14.05%(+10.0%)
14.28%(-4.6%)
Sept 2014
-
14.97%(+9.6%)
June 2014
-
13.66%(-0.6%)
Mar 2014
-
13.74%(+5.6%)
Dec 2013
12.77%(-6.9%)
13.01%(-1.6%)
Sept 2013
-
13.22%(-3.9%)
June 2013
-
13.76%(-3.3%)
Mar 2013
-
14.23%(+1.3%)
Dec 2012
13.71%
14.05%(+10.8%)
Sept 2012
-
12.68%(-0.9%)
June 2012
-
12.80%(-0.3%)
DateAnnualQuarterly
Mar 2012
-
12.84%(-4.0%)
Dec 2011
13.18%(-14.4%)
13.37%(-11.5%)
Sept 2011
-
15.10%(-1.2%)
June 2011
-
15.29%(-0.8%)
Mar 2011
-
15.42%(-4.1%)
Dec 2010
15.40%(-1.1%)
16.08%(-6.7%)
Sept 2010
-
17.24%(-3.7%)
June 2010
-
17.91%(+0.4%)
Mar 2010
-
17.84%(+9.6%)
Dec 2009
15.57%(-5.2%)
16.28%(+7.2%)
Sept 2009
-
15.19%(-0.6%)
June 2009
-
15.28%(-3.2%)
Mar 2009
-
15.79%(-3.1%)
Dec 2008
16.42%(-37.7%)
16.30%(+8.0%)
Sept 2008
-
15.09%(-40.4%)
June 2008
-
25.34%(-2.7%)
Mar 2008
-
26.03%(-2.2%)
Dec 2007
26.34%(+36.7%)
26.62%(-10.5%)
Sept 2007
-
29.73%(+55.4%)
June 2007
-
19.13%(-1.0%)
Mar 2007
-
19.33%(-0.9%)
Dec 2006
19.27%(+1.4%)
19.50%(-1.0%)
Sept 2006
-
19.70%(-1.7%)
June 2006
-
20.04%(-3.8%)
Mar 2006
-
20.83%(+6.0%)
Dec 2005
19.01%(+9.6%)
19.66%(+5.1%)
Sept 2005
-
18.70%(+1.0%)
June 2005
-
18.52%(+1.0%)
Mar 2005
-
18.33%(+4.2%)
Dec 2004
17.35%(+7.6%)
17.59%(-3.9%)
Sept 2004
-
18.30%(+1.9%)
June 2004
-
17.96%(+3.1%)
Mar 2004
-
17.42%(+4.1%)
Dec 2003
16.12%(-8.0%)
16.73%(-5.2%)
Sept 2003
-
17.64%(+3.2%)
June 2003
-
17.09%(-2.2%)
Mar 2003
-
17.48%(-6.0%)
Dec 2002
17.53%(+10.7%)
18.60%(+8.2%)
Sept 2002
-
17.19%(-2.6%)
June 2002
-
17.65%(+4.6%)
Mar 2002
-
16.88%(+0.6%)
Dec 2001
15.84%(-17.8%)
16.78%(-17.3%)
Sept 2001
-
20.29%(+8.6%)
June 2001
-
18.69%(-2.1%)
Mar 2001
-
19.10%(-4.1%)
Dec 2000
19.26%(+7.0%)
19.91%(+35.0%)
Sept 2000
-
14.75%(+34.5%)
June 2000
-
10.97%
Dec 1999
18.00%(-6.0%)
-
Dec 1998
19.14%
-

FAQ

  • What is Novartis AG annual return on equity?
  • What is the all time high annual ROE for Novartis AG?
  • What is Novartis AG annual ROE year-on-year change?
  • What is Novartis AG quarterly return on equity?
  • What is the all time high quarterly ROE for Novartis AG?
  • What is Novartis AG quarterly ROE year-on-year change?

What is Novartis AG annual return on equity?

The current annual ROE of NVS is 27.97%

What is the all time high annual ROE for Novartis AG?

Novartis AG all-time high annual return on equity is 38.59%

What is Novartis AG annual ROE year-on-year change?

Over the past year, NVS annual return on equity has changed by +17.04% (+155.90%)

What is Novartis AG quarterly return on equity?

The current quarterly ROE of NVS is 41.89%

What is the all time high quarterly ROE for Novartis AG?

Novartis AG all-time high quarterly return on equity is 41.97%

What is Novartis AG quarterly ROE year-on-year change?

Over the past year, NVS quarterly return on equity has changed by +26.97% (+180.76%)